The article was written by Hieu Nguyen, a Financial Analyst at I Know First.
Read The Full Premium Article “Our top-line performance during the first quarter reflects slightly better-than-expected growth in our OUS business driven by solid AFX growth in both the European and CAPLA markets…These accomplishments reinforce Endologix’s value proposition and our commitment to delivering the best products to physicians and patients around the globe.”
– Vaseem Mahbob, CFO of Endologix
(Source: PxHere)
Over the past 30 days, Endologix, Inc. (NASDAQ: ELGX) has been steadily climbing. Endologix, develops, produces
This article was written by Julia Masch, a Financial Analyst at I Know First.
Read The Full Premium Article 
Package Name: Small Cap Stocks
Package Name: Insiders Stocks
Package Name: Hedge Fund Stocks
Package Name: Stocks Under 5 Dollars
Disclaimer:
I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, stock forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.